Seeing Is Believing
Healthcare - Sector
NEO is currently covered by 8 analysts with an average price target of $15.38. This is a potential upside of $5.17 (-8.4%) from yesterday's end of day stock price of $16.79.
NeoGenomics's activity chart (see below) currently has 162 price targets and 137 ratings on display. The stock rating distribution of NEO is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 59.14% with an average time for these price targets to be met of 128.5 days.
Highest price target for NEO is $25, Lowest price target is $11, average price target is $15.38.
Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 29-Jul-2026. First documented stock forecast 13-Jul-2015.
Currently out of the existing stock ratings of NEO, 12 are a BUY (80%), 3 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2023
$19
$2.02 (11.90%)
$14
Buy Since 24-Jul-2026
$16
$-0.98 (-5.77%)
$11
Hold Since 28-Oct-2025
$25
$10.83 (76.43%)
$14
Buy Since 17-Dec-2021
$14
$-0.17 (-1.20%)
$14
Buy Since 28-Aug-2020
$13
$-1.17 (-8.26%)
$12
What is NEO (NeoGenomics) average time for price targets to be met?
Which analyst has the current highest performing score on NEO (NeoGenomics) with a proven track record?
Which analyst has the most public recommendations on NEO (NeoGenomics)?
Which analyst is the currently most bullish on NEO (NeoGenomics)?
Which analyst is the currently most reserved on NEO (NeoGenomics)?